v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (49,510) $ (46,496) $ (163,747)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization 19,436 16,607 17,132
Estimated credit (recoveries) losses (58) 955 1,737
Share-based compensation 2,421 3,171 4,967
Impairment loss related to goodwill and intangible assets 6,655 15,526 127,831
Impairment loss on operating lease right-of-use assets 220 133 0
Provision for deferred income taxes 0 0 (2,359)
Loss on asset disposition 685 218 568
Change in value of marketable securities (1,326) (1,438) 0
Changes in operating assets and liabilities (net of the effect of acquisitions):      
Accounts and notes receivable 835 (300) (3,106)
Inventory 24,557 13,773 32,890
Prepaid expenses and other assets 477 3,898 10,827
Accounts payable and accrued liabilities (3,712) (3,035) (3,359)
Operating leases (173) 46 508
Customer deposits (2,955) 1,021 (8,590)
Payroll and payroll tax liabilities 486 (2,502) (2,769)
Sales taxes payable 128 (156) (582)
Other 35 0 0
Net cash and cash equivalents (used in) provided by operating activities (1,799) 1,421 11,948
Cash flows from investing activities:      
Acquisitions, net of cash acquired 0 (3,050) (7,230)
Purchase of property and equipment (1,978) (6,698) (12,896)
Purchase of marketable securities (52,639) (98,680) (38,692)
Maturities of marketable securities 60,193 96,758 46,633
Proceeds from disposals of assets 150 265 612
Net cash and cash equivalents provided by (used in) investing activities 5,726 (11,405) (11,573)
Cash flows from financing activities:      
Principal payments on long-term debt 0 (50) (108)
Common stock withheld for employee payroll taxes (176) (263) (1,618)
Common stock repurchased (6,037) 0 0
Proceeds from the sales of common stock and exercise of warrants and options, net of expenses 0 0 33
Net cash and cash equivalents used in financing activities (6,213) (313) (1,693)
Net decrease in cash and cash equivalents (2,286) (10,297) (1,318)
Cash and cash equivalents at beginning of year 29,757 40,054 41,372
Cash and cash equivalents at end of year 27,471 29,757 40,054
Supplemental Information:      
Cash paid for interest 70 98 21
Cash paid for income taxes 125 93 0
Right-of-use assets obtained in exchange for new or modified operating lease liabilities 3,506 4,289 9,607
Non-cash repurchase of liability awards 0 653 0
Non-cash issuance of a note receivable 0 299 0
Liability redemption associated with business acquisition 0 120 0
Indemnity holdback from business acquisition 0 0 875
Common stock issued for business combinations 0 0 5,710
Common stock issued for intangible assets $ 0 $ 0 $ 173

Source

HTML PDF
ZIP